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Polydatin (3,4’,5-trihydroxystilbene-3-β-d-glucoside) is a natural precursor of res-
veratrol already approved for commercialization as food supplement. It is present 
in many types of plants, including grape, peanut, and cassia seed where it acts as 
antimycotic agent. Polydatin has been proposed to have effect on cancer, including 
HNSCC and breast cancer, with promising results, but its mechanism of action seems 
to be different from resveratrol and is poorly understood. Glucose-6-phosphate dehy-
drogenase (G6PD) is the limiting enzyme of the pentose phosphate pathway which 
have been widely shown to be fundamental for tumor growth and metastasis forma-
tion. In this work our results show that polydatin inhibit G6PD in a dose dependent 
manner affecting cancer cell viability, causing a dose-dependent apoptosis and cell 
cycle arrest. Moreover, treated cells showed a strong increase of the Unfolded Protein 
Response (UPR), activated by a stress in the endoplasmic reticulum (ER), autophagy, 
reduced migration and invasion ability. Moreover, we developed a metastatic ortho-
topic HNSCC model in immunocompromised mice and showed that treated group 
had reduced tumor growth and reduce lymph nodes metastases. In conclusion here 
we show that Polydatin exerts a significant inhibitory effect on pentose phosphate 
pathway inhibiting HNSCC growth and metastases, pointing out that polydatin may 
be a reliable anticancer drug.
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